Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
RNA-seq (gene expression) · human · 102 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Kidney cancerThis series is part of our curated briefing on it.
- Samples
- 102 samples: 102 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic SimilarityCancer research communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE289907_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1225288. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 58 samples read as cases, 44 as controls.
How we read this: Read from 102 sample titles: 102 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8801225 PT1_Tumor
- GSM8801226 PT1_Normal
- GSM8801227 PT2_Tumor
- GSM8801228 PT2_Normal
- GSM8801229 PT5_Tumor
- GSM8801230 PT6_Tumor
- GSM8801231 PT8_Tumor
- GSM8801232 PT8_Normal
- GSM8801233 PT13_Tumor
- GSM8801234 PT14_Tumor
- GSM8801235 PT15_Tumor
- GSM8801236 PT15_Normal
- GSM8801237 PT16_Tumor
- GSM8801238 PT16_Normal
- GSM8801239 PT19_Tumor
- GSM8801240 PT19_Normal
- GSM8801241 PT21_Tumor
- GSM8801242 PT24_Tumor
- GSM8801243 PT24_Normal
- GSM8801244 PT27_Tumor
- GSM8801245 PT27_Normal
- GSM8801246 PT28_Tumor
- GSM8801247 PT29_Tumor
- GSM8801248 PT30_Tumor
- GSM8801249 PT30_Normal
- GSM8801250 PT31_Tumor
- GSM8801251 PT32_Tumor
- GSM8801252 PT32_Normal
- GSM8801253 PT33_Tumor
- GSM8801254 PT35_Tumor
- GSM8801255 PT35_Normal
- GSM8801256 PT36_Tumor
- GSM8801257 PT36_Normal
- GSM8801258 PT37_Tumor
- GSM8801259 PT37_Normal
- GSM8801260 PT41_Tumor
- GSM8801261 PT41_Normal
- GSM8801262 PT42_Tumor
- GSM8801263 PT42_Normal
- GSM8801264 PT43_Tumor
+ 62 more — browse all 102 samples with per-sample file links →
- GSE193006 Transcriptome RNA sequencing data of sarcomatoid renal cell carcinoma cell line SRCC and its subclones with different phenotypes. 5 samples same disease briefing · shares differ, renal
- GSE216495 Nonclinical in-vitro evaluation of the transcriptomic and metabolic effects of immune checkpoint inhibitors on sunitinib-resistant renal cell carcinoma 36 samples same disease briefing · shares renal
- GSE216494 Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro 12 samples same disease briefing · shares renal
- GSE174740 Drug repurposing identifies a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma 11 samples same disease briefing · shares renal
- GSE15641 Gene signatures of progression and metastasis in renal cell cancer 92 samples same disease briefing · shares renal
- GSE19982 Gene expression discriminates chromophobe renal cell carcinoma and oncocytoma 30 samples same disease briefing · shares renal
- GSE214635 The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis 18 samples same disease briefing
- GSE223688 SETD2 loss sensitizes kidney cancer cells to DNA hypomethylating agents 6 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.